• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [21936 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2020     Malaysian Health Technology Assessment (MaHTAS) Targeted therapies in combination with hormonal therapy as a first-line treatment for HR+ and HER2- metastatic breast cancer
2020     European Network for Health Technology Assessment (EUnetHTA) Pretomanid in combination with bedaquiline and linezolid in adults for the treatment of pulmonary extensively drug-resistant (XDR), or treatment-intolerant or nonresponsive multidrug-resistant (MDR) tuberculosis (TB)
2020     Malaysian Health Technology Assessment (MaHTAS) Refurbished medical device
2020     NIHR Health Technology Assessment programme Surgical treatments compared with early structured physiotherapy in secondary care for adults with primary frozen shoulder: the UK FROST three-arm RCT
2020     NIHR Health Services and Delivery Research programme Learning about and learning from GP Federations in the English NHS a qualitative investigation
2020     European Network for Health Technology Assessment (EUnetHTA) Remdesivir or the treatment of COVID-19. PICO and evidence gaps
2020     Malaysian Health Technology Assessment (MaHTAS) Resuscitative endovascular balloon occlusion of the aorta (REBOA)
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Simulation-based education in surgery: cost-effectiveness and resource use
2020     European Network for Health Technology Assessment (EUnetHTA) Remdesivir for the treatment of COVID-19
2020     Malaysian Health Technology Assessment (MaHTAS) Transbronchial cryobiopsy for lung biopsy in interstitial lung disease
2020     European Network for Health Technology Assessment (EUnetHTA) Dexamethasone for the treatment of hospitalised patients with COVID-19
2020     Malaysian Health Technology Assessment (MaHTAS) Hepatitis C virus screening and surveillance tests for dialysis patients
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Vaccination contre la grippe dans le contexte particulier de la pandémie COVID-19 : intérêt et populations prioritaires
2020     NIHR Health Technology Assessment programme A multicentre randomised trial to establish the effect(s) of routine administration of fluoxetine in patients with a recent stroke (FOCUS)
2020     Malaysian Health Technology Assessment (MaHTAS) Strategies to eliminate mother to child transmission of hepatitis B in Malaysia
2020     NIHR Health Technology Assessment programme Effectiveness of progesterone to prevent miscarriage in women with early pregnancy bleeding: a randomised placebo-controlled trial (PRISM Trial: PRogesterone In Spontaneous Miscarriage Trial)
2020     Malaysian Health Technology Assessment (MaHTAS) Pneumococcal vaccination with 23-valent polysaccharide vaccine (PPV23) for elderly
2020     Scottish Health Technologies Group (SHTG) HeartFlow FFRCT for estimating fractional flow reserve from coronary CT angiography
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Patient information on interstitial low-dose-rate brachytherapy for localized prostate cancer - addendum to commission N17-04]
2020     Health Technology Wales (HTW) Single-operator per-oral cholangioscopy for the management of hepatobiliary-pancreatic disorders
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vertebroplasty or kyphoplasty in patients with symptomatic osteoporotic vertebral compression fractures unresponsive to non-surgical treatment
2020     Health Technology Wales (HTW) Remote monitoring of blood glucose in women with gestational diabetes
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Chloroquine et Hydroxychloroquine dans le traitement de la COVID-19
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Guideline synopsis for the DMP "type 2 diabetes"]
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) Place des tests de diagnostic rapide dans la stratégie de prise en charge de la COVID-19 : Complément d’informations du 22 Mai 2020
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) The treatment of primary hypercholesterolaemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
2020     NIHR Health Technology Assessment programme Cognitive Rehabilitation for Attention and Memory in people with Multiple Sclerosis (CRAMMS)
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Chondroitin sulfate in osteoarthritis
2020     NIHR Public Health Research (PHR) programme Understanding the impact of tobacco tax increases and tobacco industry pricing on smoking behaviours and inequalities
2020     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Tisagenlecleucel (reassessment after expiry: diffuse large B-cell lymphoma)]
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Subacromial decompression for rotator cuff disease
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Portrait of coronary revascularization by percutaneous coronary intervention and coronary bypass grafting in Quebec, 2015-2018]
2020     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Volanesorsen]
2020     NIHR Health Technology Assessment programme Annual mammographic screening to reduce breast cancer mortality in women from age 40 years: long-term follow-up of the UK Age RCT
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Vertebroplasty or kyphoplasty in patients with symptomatic osteoporotic vertebral compression fractures unresponsive to non-surgical treatment [HTA scoping report protocol]
2020     Andalusian Health Technology Assessment Area (AETSA) Cognitive training effectiveness for mild to moderate dementia patients. A systematic review
2020     National Authority for Assessment and Accreditation in Healthcare (INEAS) [Disinfection chambers/tunnels in the context of COVID-19 pandemic]
2020     Andalusian Health Technology Assessment Area (AETSA) Genetic risk prediction test for cardiovascular disease
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Intrauterine ultrasound-guided radiofrequency ablation
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Clinical Efectiveness of Newborn Screening for Inborn Errors of Metabolism by MS/ MS. Update and pilot study assessment: Maple Syrup Urine Disease; Isovaleric Acidaemia; Homocystinuria]
2020     Andalusian Health Technology Assessment Area (AETSA) Efficacy, effectivity and safety of physical therapies for neuromuscular diseases: systematic review
2020     European Network for Health Technology Assessment (EUnetHTA) Hypoglossal nerve stimulation systems for treatment of obstructive sleep apnea
2020     Andalusian Health Technology Assessment Area (AETSA) Effectiveness and safety of MAGnetic Expansion Control (MAGEC) growing rods. Evidence Update.
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Treatment of benign thyroid by thermal laser or radiofrequency ablation]
2020     NIHR Health Technology Assessment programme Interventions for adults with a history of complex traumatic events: the INCiTE mixed-methods systematic review
2020     European Network for Health Technology Assessment (EUnetHTA) Biodegradable rectum spacers to reduce toxicity for prostate cancer
2020     NIHR Health Technology Assessment programme Thoracoscopy and talc poudrage compared with intercostal drainage and talc slurry infusion to manage malignant pleural effusion: the TAPPS RCT
2020     European Network for Health Technology Assessment (EUnetHTA) The 24-hour blood pressure measurement device Mobil-O-Graph® with the built-in algorithm ARCSolver® to measure arterial stiffness for the optimization of hypertension treatment and assessment of cardiovascular disease risk
2020     NIHR Health Technology Assessment programme Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review
2020     NIHR Health Technology Assessment programme Occupational advice to help people return to work following lower limb arthroplasty: the OPAL intervention mapping study
2020     NIHR Health Services and Delivery Research programme Medication management in older people: the MEMORABLE realist synthesis
2020     European Network for Health Technology Assessment (EUnetHTA) Lung cancer screening in risk groups
2020     NIHR Health Technology Assessment programme Denosumab, raloxifene, romosozumab and teriparatide to prevent osteoporotic fragility fractures: a systematic review and economic evaluation
2020     European Network for Health Technology Assessment (EUnetHTA) Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-COV-2 in the management of the pandemic
2020     European Network for Health Technology Assessment (EUnetHTA) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of SARS-COV-2 virus in people with suspected COVID-19
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Moving on from 2020 and looking forward to 2021 with a new and continuous publication model
2020     NIHR Health Technology Assessment programme Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT
2020     European Network for Health Technology Assessment (EUnetHTA) Lopinavir and ritonavir for the treatment of COVID-19
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) ASERNIP-S: unusual acronym, outstanding results
2020     Norwegian Institute of Public Health (NIPH) Abdominal aorta aneurysm (AAA) screening of men aged 65
2020     Malaysian Health Technology Assessment (MaHTAS) Pulsed electromagnetic field therapy – an update
2020     Malaysian Health Technology Assessment (MaHTAS) Repetitive transcranial magnetic stimulation (rTMS) for patients with stroke
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ibrutinib (new therapeutic indication, chronic lymphocytic leukaemia) - Benefit assessment according to §35a Social Code Book V]
2020     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Proposal for the organization of bariatric medicine for the territories of the integrated university health and social services network of Laval University]
2020     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Exploratory evaluation of the relevance, use, and impacts of teleconsultations]
2020     Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval) [Field evaluation of the implementation of video teleconsultations during the COVID-19 pandemic at the Quebec Heart and Lung Institute]
2020     NIHR Health Services and Delivery Research programme Enhancing the credibility, usefulness and relevance of patient experience data in services for people with long-term physical and mental health conditions using digital data capture and improved analysis of narrative data (DEPEND)
2020     NIHR Health Services and Delivery Research programme The role of hospital organisation, surgical factors, and the enhanced recovery pathway, on patient outcomes and NHS costs following primary hip and knee replacement surgery: spatial and longitudinal analysis of routine data
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ropeginterferon alfa-2b (polycythaemia vera) - Benefit assessment according to §35a Social Code Book V]
2020     NIHR Health Services and Delivery Research programme Implementation of an evidence based pelvic floor muscle training intervention for women with pelvic organ prolapse (PROlapse and PFMT: implementing Evidence Locally - PROPEL)
2020     Health Technology Wales (HTW) Rapid collaborative review on the diagnostic accuracy of molecular methods that detect the presence of the SARS-COV-2 virus in people with suspected COVID-19
2020     NIHR Health Services and Delivery Research programme ERA Electronic Records in Ambulances to support the shift to out of hospital care: challenges, opportunities and workforce implications
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: continuous glucose monitoring system (Dexcom G6, Dexcom)]
2020     NIHR Health Services and Delivery Research programme Dementia undetected or undiagnosed in primary care: the prevalence, causes and consequences
2020     NIHR Health Technology Assessment programme Surgical interventions for uterine prolapse and for vault prolapse: the two VUE RCTs
2020     NIHR Health Technology Assessment programme Validation and development of models using clinical, biochemical and ultrasound markers for predicting pre-eclampsia: an individual participant data meta-analysis
2020     NIHR Health Technology Assessment programme Open urethroplasty versus endoscopic urethrotomy for recurrent urethral stricture in men: the OPEN RCT
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: Takhzyro (lanadelumab), notice of inclusion on the Liste des produits du système du sang du Québec]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Atezolizumab (NSCLC, combination chemotherapy with nab-paclitaxel) - Benefit assessment according to §35a Social Code Book V]
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: tomosynthesis and breast cancer: diagnostic evaluation and other uses]
2020     Canary Health Service [Cost-effectiveness of universal childhood vaccination against hepatitis A (update)]
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Personal protective equipment and evidence-based advice for surgical departments during COVID-19
2020     NIHR Health Technology Assessment programme An online randomised controlled trial to evaluate the clinical and cost effectiveness of a peer supported self-management intervention for relatives of people with psychosis or bipolar disorder: Relatives Education And Coping Toolkit (REACT)
2020     Swiss Federal Office of Public Health (FOPH) Dual antiplatelet therapy following percutaneous coronary intervention
2020     Canary Health Service [Liquid biopsy for the detection of ovarian or endometrial cancer in samples taken from the Pap smear: PapSEEK]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cannabidiol (Dravet syndrome) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Surgery triage during the COVID-19 pandemic
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: first-line treatment of oral candidiasis in adults]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Cannabidiol (Lennox-Gastaut syndrome) - Assessment according to §35a (para. 1., sentence 11) Social Code Book V]
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Screening and testing for COVID-19 before surgery
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: pharmacological treatment for fecal elimination in a person receiving palliative care or presenting a geriatric profile]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Development of scientific concepts for the generation of routine practice data and their analysis for the benefit assessment of drugs according to §35a Social Code Book V - rapid report]
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Safe surgery during the coronavirus disease 2019 crisis
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [National medical protocols and associated prescriptions: initiating a blood profile after detecting suggestive symptoms and signs of mild or major neurocognitive disorder]
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Trifluridine/tipiracil (gastric cancer) - Benefit assessment according to §35a Social Code Book V]
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Surgery triage: responding to the COVID-19 pandemic. A rapid review comissioned by RACS
2020     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Asfotase alfa (hypophosphatasia) - Benefit assessment according to §35a Social Code Book V]
2020     Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Guidelines for safe surgery: open versus laparoscopic. A rapid review commissioned by RACS
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use of immunoglobulins in hematology]